Skip to main content
logo
Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.2730
-0.0030 (-1.09%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Scinai Immunotherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.211.310.66---
Revenue Growth
-99.24%----
Gross Profit
-4-2.65-0.58---
Operating Income
0.452.247.489.71-11.06-10.86
Net Income
6.492.2422.249.71-16.338.21
Earnings Per Share
2.323.60-16.0040.00-80.00
EPS Growth
-78.92%---60.00%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.961.661.964.8714.0817.37
Total Debt
3.52.272.0920.5621.5428.99
Net Cash (Debt)
-0.53-0.61-0.12-15.69-7.47-11.61
Net Cash Growth
------
Net Cash Per Share
-0.19-0.26-0.15-40.17-39.61-82.26

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.45-6.03-6.34-9.38-7.27-7.43
Capital Expenditures
-0.02-0.02-0.01-0.64-0.84-0.14
Free Cash Flow
-6.46-6.06-6.35-10.02-8.1-7.57
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-329.32%-202.29%-88.15%---
Operating Margin
36.66%170.71%1136.47%---
Pretax Margin
534.51%170.71%3379.48%---
Profit Margin
534.51%170.71%3379.48%---
FCF Margin
-532.46%-461.86%-964.59%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-0.20-0.370.74-
PS Ratio
0.891.884.34---